Table 1.
Number of patients (%) | |
Severity of edema* | |
None | 4 (20)† |
Mild | 10 (50) |
Moderate | 3 (15) |
Severe | 3 (15) |
Type of edema | |
Venous stasis | 10 (50) |
Lipedema‡ | 4 (20) |
Lymphedema | 1 (5) |
Two or more | 2 (10) |
None | 3 (15) |
Mean age, years (range) | 70.2 (59 to 85) |
Gender, women | 14 (70) |
Race, white | 20 (100) |
Mean weight, kg (range) | 91.8 (59.4 to 133.4) |
Mean body mass index (kg/m2 ) | 33.1 (20.8 to 45.8) |
Concurrent conditions | |
Hypertension | 17 (85) |
Dyslipidemia/hyperlipidemia | 17 (85) |
Coronary artery disease | 6 (30) |
Chronic heart failure | 4 (20) |
Dyspnea | 2 (10) |
Venous insufficiency | 1 (5) |
Renal insufficiency | 4 (20) |
Arthritis | 6 (30) |
Concomitant medications§ | |
Anti-hypertensive medication, excluding diuretics | 18 (90) |
Diuretics | 14 (70) |
Lipid-altering medication | 9 (45) |
Non-steroidal anti-inflammatory agents | 2 (10) |
Thiazolidinediones | 1 (5) |
Insulin | 7 (35) |
* Initial classification of edema was determined by a physician and based upon the classic clinical assessment of edema. Efforts were made to recruit patients with a range of edema severity and patients with no edema.
† One patient was classified as having a medical history of edema consistent with lipedema but no edema was present at the time of the study.
‡ Lipedema is a entity distinguished clinically from lymphedema by the presence of soft symmetrical tissue enlargement of the lower extremities with sparing of the foot, ankle and upper extremities.[1]
§ Medications taken on the day of the visit.